Hennion & Walsh Asset Management, Inc. Acadia Pharmaceuticals Inc Transaction History
Hennion & Walsh Asset Management, Inc.
- $1.89 Billion
- Q2 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 102,477 shares of ACAD stock, worth $1.82 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
102,477
Previous 142,998
28.34%
Holding current value
$1.82 Million
Previous $2.64 Million
37.03%
% of portfolio
0.09%
Previous 0.14%
Shares
14 transactions
Others Institutions Holding ACAD
# of Institutions
302Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$761 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$245 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$236 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$207 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$107 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.87B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...